Alain DumontPh.D.


Partner | Patent Agent

Alain Dumont is a partner and patent agent in Lavery’s intellectual property group. He is a registered patent agent in Canada and the United States, joined the firm in January 2006 and was named partner in January 2016. He specializes in drafting and prosecuting patent applications, and providing validity, infringement, freedom to operate and patentability opinions, and also provides strategic advice to clients regarding patent portfolio management. Dr. Dumont has also been involved in appeal proceedings before the Patent Appeal Board in Canada and the Patent Trial and Appeal Board of the United States Patent and Trademark Office.

Alain’s main areas of practice are biotechnology and pharmaceutical. He has particular expertise in the areas of immunology and vaccinology, as well as in biochemistry, genomics, proteomics, and molecular and cellular biology.

He graduated from Université de Montréal in 1997 with an Honours Bachelor of Science Degree in biochemistry, and received his doctorate of philosophy in immunology from McGill University in 2003. Before joining the firm, he worked as an associate to the scientific director of a Network of Centres of Excellence dedicated to the development of vaccines.


  • Dumont, A. and Tolszczuk-Landry, S.-C., “Survol des décisions et des modifications législatives significatives en matière de brevets pharmaceutiques en 2017”, Les Cahiers de la Propriété Intellectuelle, Vol. 30, No. 2, May 2018
  • Dumont, A. and Shahinian, S., “Medical use claims not involving the professional skill of a physician are patent-eligible in Canada”, GGData Newsletter, August 1, 2017
  • Dumont, A. and Shahinian, S., “Double Patenting Under Canadian Patent Law”, GGData Newsletter, December 7, 2016
  • Dumont, A. and Leibovitch, M., “Les agents de brevets et le secret professionnel”, Les Cahiers de la Propriété Intellectuelle, Vol. 28, No. 3, October 2016 
  • Dumont, A. and Shahinian, S., “Recent developments on patent-eligibility of medical use claims in Canada”, GGData Newsletter, April 7, 2015
  • Dumont, A. and Shahinian, S. “Brevetabilité et définition de l’invention”, JurisClasseur Québec, Coll. “Droit des affaires”, Propriété intellectuelle, fasc. 23, Montréal


  • “When to think about asking for a patent in research?”, Subvention nationale de formation des IRSC sur l’hépatite C (NCRTP-HepC), 2014
  • “Brevets et inventorship en milieu académique”, 2e atelier sur la propriété intellectuelle d’IRICoR, 2013
  • “Quand le brevet se fait élastique”, Université Laval, 2012
  • “La recherche et les brevets”, Institut Armand-Frappier, 2011
  • “Introduction à la propriété intellectuelle”, Université de Montréal, 2010
  • “Patent Agent: The bridge between the Lab and the Law”, McGill University, 2007

Professional and community activities

  • Member of the Life Sciences Committee of Intellectual Property Institute of Canada since 2017
  • Organizing committee of the Fête Champêtre, Fondation Armand-Frappier, 2016 


  • Winner of the “Client Choice Awards 2014” in the Intellectual Property – Patents category in Québec
  • Doctoral Research Award, Canadian Institutes of Health Research (IRSC/CIHR), April 2000 to March 2003


  • Diplomas
    • Ph.D. Experimental Medicine (Immunology), McGill University, 2003
    • B.Sc. Biochemistry, Université de Montréal, 1997
    • D.E.S.S. in Management, HEC Montréal, 2004
  • Continuing Education
    • “Understanding Patents: An Introductory Course”, Intellectual Property Institute of Canada and McGill Centre for Continuing Education, 2006
    • “Patent Protection in Biotechnology: Issues and Strategies for Effective Protection”, Biotechnology Human Resource Council, 2005
    • “Good Clinical Practices”, Biotechnology Human Resource Council, 2005

Boards and Professional Affiliations

  • Intellectual Property Institute of Canada (IPIC)
  • United States Patent and Trademark Office (USPTO)
  • The Association of University Technology Managers (AUTM)
Back to the Team page